Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 5:11:42.
doi: 10.1186/1471-2474-11-42.

Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia

Affiliations

Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia

Björn Gerdle et al. BMC Musculoskelet Disord. .

Abstract

Background: fibromyalgia is a relatively common condition with widespread pain and pressure allodynia, but unknown aetiology. For decades, the association between motor control strategies and chronic pain has been a topic for debate. One long held functional neuromuscular control mechanism is differential activation between regions within a single muscle. The aim of this study was to investigate differences in neuromuscular control, i.e. differential activation, between myalgic trapezius in fibromyalgia patients and healthy controls.

Methods: 27 fibromyalgia patients and 30 healthy controls performed 3 minutes bilateral shoulder elevations with different loads (0-4 Kg) with a high-density surface electromyographical (EMG) grid placed above the upper trapezius. Differential activation was quantified by the power spectral median frequency of the difference in EMG amplitude between the cranial and caudal parts of the upper trapezius. The average duration of the differential activation was described by the inverse of the median frequency of the differential activations.

Results: the median frequency of the differential activations was significantly lower, and the average duration of the differential activations significantly longer in fibromyalgia compared with controls at the two lowest load levels (0-1 Kg) (p < 0.04), but not at the two highest load levels (2 and 4 Kg).

Conclusion: these findings illustrate a different neuromuscular control between fibromyalgia patients and healthy controls during a low load functional task, either sustaining or resulting from the chronic painful condition. The findings may have clinical relevance for rehabilitation strategies for fibromyalgia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Experimental setup. Posterior view of a subject, electromyographical electrode device (rectangle), and weight harness. The centre of the electrode-device was placed in the middle of the line between processus spinosus of the C7 vertebra and the lateral edge of acromion. The harness was used to attach weights symmetrically on the shoulders. Subjects performed isometric shoulder elevation such that their shoulders were held in the horizontal plane.
Figure 2
Figure 2
Examples of a normalized muscle activity from a high-density EMG recording (caudal - cranial, channel 1 to 10, 5 mm's apart) from one healthy control (A) and one patient with fibromyalgia (C) performing a 1 kg weight of isometric shoulder elevation. The activity difference (B and D) in normalized activity between caudal and cranial regions segments (see A right) were used to calculate the power spectral median frequency.
Figure 3
Figure 3
Examples of the power spectral density (Psd) of the differential activity signal between the cranial and caudal parts of the trapezius and its corresponding median frequency (MDF), for a healthy control (A) and a patient with fibromyalgia (B).
Figure 4
Figure 4
Mean values and 95% confidence intervals for median frequency of the differential activations for healthy controls and patients with fibromyalgia at different weights. Furthest to the right is shown the difference between the two groups.

Similar articles

Cited by

References

    1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain. 2006;10:287–333. doi: 10.1016/j.ejpain.2005.06.009. - DOI - PubMed
    1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism. 1998;41:778–799. doi: 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V. - DOI - PubMed
    1. White KP, Speechley M, Harth M, Ostbye T. The London fibromyalgia epidemiology study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. Journal of Rheumatology. 1999;26:1577–1585. - PubMed
    1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general-population. Arthritis and Rheumatism. 1995;38:19–28. doi: 10.1002/art.1780380104. - DOI - PubMed
    1. Bennett RM. Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia. Mayo Clinic Proceedings. 1999;74:385–398. doi: 10.4065/74.4.385. - DOI - PubMed

Publication types

MeSH terms